Baidu
map

重症脑损伤患者镇痛镇静有了专家共识

2013-08-12 匡远深 健康报

镇痛镇静治疗对重症脑损伤患者有何作用?重症脑损伤在镇痛镇静治疗过程中如何监测?低温治疗如何选择镇痛镇静药物?日前,中国医师协会神经外科医师分会神经重症专家委员会发布“重症脑损伤患者镇痛镇静专家共识”,为这些问题给出了专业的指导方案。 我国每年约有60万名重症颅脑损伤病人,死亡约10万人。以往颅脑损伤临床救治没有标准,多凭医生经验用药,治疗上存在很大的盲目性。共识执笔人、首都医科大学附属北

镇痛镇静治疗对重症脑损伤患者有何作用?重症脑损伤在镇痛镇静治疗过程中如何监测?低温治疗如何选择镇痛镇静药物?日前,中国医师协会神经外科医师分会神经重症专家委员会发布“重症脑损伤患者镇痛镇静专家共识”,为这些问题给出了专业的指导方案。

我国每年约有60万名重症颅脑损伤病人,死亡约10万人。以往颅脑损伤临床救治没有标准,多凭医生经验用药,治疗上存在很大的盲目性。共识执笔人、首都医科大学附属北京天坛医院副院长周建新教授介绍,共识涵盖五方面问题:重症脑损伤患者镇痛镇静的目的,重症脑损伤患者在镇痛镇静治疗过程中的监测,镇痛镇静药物选择,镇痛镇静治疗在难治性高颅压中的作用及镇痛镇静药物在低温治疗中的应用。

共识认为,镇痛镇静治疗是重症脑损伤患者临床处理的重要组成部分,除了控制焦虑、躁动和疼痛,减轻应激反应,提高机械通气的协调性,减轻医疗护理操作对患者造成的伤害性刺激外,更重要的是发挥脑保护作用,维持脑氧供需平衡,提高患者舒适度和预后效果。

共识指出,重症脑损伤患者应用镇静剂前,应首先控制疼痛、纠正生理学异常(如低氧血症、低血压和低血糖等)。当以控制躁动为主要目的时,应定时监测镇静程度,宜维持较浅的镇静深度。同时,应建立定时和及时意识评估。某些情况下,躁动是颅内压升高的初期表现,若不加以排除地应用镇静药物,可能掩盖颅内病情变化,延误治疗时机。镇静深度监测在危重患者中的重要性已获得广泛认同,将患者维持于较浅的镇静深度是最新共识的特点。

在药物选择上,共识提出了应遵循的两个基本原则:对中枢神经系统无附加损害;药物作用能够快速消除。镇痛镇静药物常用于低温治疗过程中,目的在于辅助降温并预防和控制寒战。镇静药物也是控制癫痫持续状态的常用药物之一。据介绍,欧美国家在低温治疗过程中常规使用泮库溴铵和顺式阿曲库铵。而国内低温治疗多采用冬眠合剂,其优点在于降低体温调定阈值。大剂量镇静药物,尤其是巴比妥类药物,常作为其他内科和外科治疗手段无效时的挽救性治疗措施,用于难治性颅高压的控制。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]
    2015-07-11 保守主义

    ?▂?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]
    2013-08-14 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=32337, encodeId=79953233ea5, content=?▂?, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0f31631005, createdName=保守主义, createdTime=Sat Jul 11 10:50:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1844417, encodeId=7495184441e89, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Nov 26 03:18:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028333, encodeId=cab22028333b2, content=<a href='/topic/show?id=b1929680e5c' target=_blank style='color:#2F92EE;'>#镇痛镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96807, encryptionId=b1929680e5c, topicName=镇痛镇静)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Thu Dec 19 20:18:00 CST 2013, time=2013-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814738, encodeId=82d81814e38fd, content=<a href='/topic/show?id=3bec959e858' target=_blank style='color:#2F92EE;'>#重症脑损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95978, encryptionId=3bec959e858, topicName=重症脑损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 25 06:18:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355196, encodeId=67b21355196fd, content=<a href='/topic/show?id=256a96e9990' target=_blank style='color:#2F92EE;'>#镇痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96799, encryptionId=256a96e9990, topicName=镇痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396779, encodeId=11e41396e7957, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Wed Aug 14 08:18:00 CST 2013, time=2013-08-14, status=1, ipAttribution=)]

相关资讯

我国推出重症脑损伤患者镇痛镇静专家共识

镇痛镇静药物对重症脑损伤病人意识评估有何影响?镇痛镇静治疗在缺乏高级别循证医学证据时,尤其是对远期神经系统转归又有何影响?在低温治疗中如何选择应用镇痛镇静药物?这些以往临床有争议的话题而今有了专业性的指导方案。日前,中国医师协会神经外科医师分会神经重症专家委员会正式发布了“重症脑损伤患者镇痛镇静专家共识”(以下简称共识),以其规范神经重症医学的临床医疗实践,这对提高我国重症脑损伤病人的救治水平具有

河豚毒素或可用于缓解癌痛

     哈肯萨克市明尼苏达大学约翰陶依尔癌症中心的研究人员正探究新的治疗方法缓解因癌症治疗所带来的疼痛,以替代现有副作用诸多的阿片类药物治疗。这个治疗方案所用到的有效成分是豚毒素,是一种河豚体内的神经毒素。   约翰陶依尔癌症中心大脑和脊柱研究所的首席研究员兼联席主任,医学博士Samuel Goldlust说:“化疗法导致的神经性疼痛使

Baidu
map
Baidu
map
Baidu
map